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MinireviewA SLAT in the Th2 Signalosome
protein (SAP) in the regulation of Th1/Th2 differentiationJoaquı´n Madrenas
(Fields and Flavell, 2001; Nichols et al., 2001), and theThe Robarts Research Institute and
article by Tanaka et al. (2003) reporting the initial charac-The Department of Microbiology and Immunology and
terization of a molecule that regulates TCR-mediatedThe Department of Medicine
signaling in a way that favors the differentiation of CD4The University of Western Ontario
T cells into Th2 cells.London, Ontario
Using differential display of Th2-associated genes,Canada N6A 5K8
Tanaka et al. isolated a sequence coding for a protein
with significant homology to SWAP-70, a molecule de-
scribed to be associated with the BCR (Masat et al.,
2000). They called the resulting protein SLAT, for SWAT-There is abundant information on the distinguishing
70-like adapter molecule of T cells. SLAT is expressedfeatures of TCR-mediated signaling in Th1 and Th2
in thymocytes and primary T cells. Four days after stimu-cells. However, the primary signals that determine the
lation, SLAT is upregulated in polarized Th2 cells,commitment and differentiation of naive T cells toward
whereas its expression is downregulated in polarizedthose T helper subsets, especially prior to the contri-
Th1 cells. This time course of expression suggests thatbution of polarizing cytokines, remain elusive. This mini-
SLAT is not specifically involved in the initial TCR signal-review discusses the potential contribution of SLAT in
ing events that commit the T cells to a Th2 lineage butfavoring differentiation along the Th2 lineage and how
rather is involved in the TCR signaling events favoringthis may bring us closer to a framework model for
the differentiation of already committed Th2 cells, priorTh1/Th2 differentiation.
to or independently of polarizing cytokine effects. This
suggestion is supported, with the reservations associ-The Th1 and Th2 profiles of cytokine production by acti-
ated with overexpression experiments, by the observa-vated CD4 T cells are linked to cell-mediated immunity
tion that increased SLAT expression increases IL-4 pro-or humoral immunity, respectively. This association has
duction and downregulates IFN- production. From abeen a useful paradigm for understanding fundamental
mechanistic point of view, SLAT is associated to themechanisms of T cell commitment and differentiation
cell membrane and clusters at putative immunologicalduring immune responses. The translational implica-
synapses upon antigenic stimulation of T cells. Moretions of this paradigm are tantalizing since those steps
importantly, SLAT “competes” with phosphorylatedthat are specific for polarization of activated CD4
TCR- for association with ZAP-70, and such associa-T cells into the Th1 or the Th2 phenotype may serve as
tion inhibits ZAP-70 activation. Details about the SLAT-therapeutic targets. In the hunt for these key steps, it
ZAP-70 interaction and the basis for SLAT recruitmentwas soon discovered that the presence of interleukin
to the synapse are not known.(IL)-12 or IL-4 in the priming event plays a critical role
The identification of SLAT brings us closer to the char-for the development of Th1 or Th2 cells, respectively
acterization of a TCR-dependent signalosome partici-
(Murphy et al., 2000). However, the availability of these
pating in the differentiation of Th2 cells. Current data
cytokines to responding T cells is a reflection of cell
indicate that preferential differentiation into the Th1 or
activation. Furthermore, the lack of responsiveness to Th2 phenotypes correlates with differences in the affinity
these cytokines, for example as a result of lack of ex- of the TCR for its peptide:MHC ligand and/or the require-
pression of IL-12 by the APC or of STAT-6 by T cells, ment for costimulation (Leitenberg et al., 2001). Specifi-
does not prevent T cells from polarizing (Noble et al., cally, Th2 differentiation is often the result of low-affinity
2001; Ouyang et al., 2000). This type of observation interactions between the TCR and its ligand, requiring
pointed to differences in antigen recognition by the T cell longer times of T cell stimulation (Iezzi et al., 1999) and
antigen receptor (TCR), which likely translates into dif- participation of CD4 (Fowell et al., 1997). These mem-
ferences at the level of TCR signal transduction and at brane events translate into an early signaling pattern
the level of transcriptional changes as critical for Th1/ that is dependent on lck (Boutin et al., 1997) and Itk
Th2 differentiation. (Fowell et al., 1999) but not on ZAP-70, causing a low
The identification of parameters linked with Th1/Th2 tyrosine phosphorylation of intracellular proteins. Fur-
commitment during antigen recognition (e.g., antigen ther downstream, antigen stimulation of Th2 cells is of-
dose, signal “strength,” costimulation) and during tran- ten associated with transient and lower activation of
scriptional activation (i.e., T-bet for Th1-lineage cells MAPK than that seen with Th1 cells, and low calcium
and GATA-3 and c-maf for Th2-lineage cells) has been fluxing. Overall, this pattern of TCR-dependent signaling
very successful. In contrast, the search for unique sig- favors nuclear translocation of NT-ATc over NF-ATp and
naling complexes associated with lineage differentiation selective DNA demethylation and chromatin remodeling
(what I call Th1 or Th2 signalosomes) has been more for GATA-3-dependent genes such as the IL-4 and the
elusive. This may be about to change with the increasing IL-13 genes (reviewed in Murphy et al., 2000). In this
evidence for a role of the signaling lymphocytic activa- context, SLAT may constitute the first example of a
tion molecule (SLAM, CD150) and SLAM-associated signaling molecule specifically associated to this pattern
of signaling that promotes Th2 differentiation before cy-
tokine-induced polarization as suggested by Tanaka etCorrespondence: madrenas@robarts.ca
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al. This claim is based on the temporal profile of expres- and likely modulates signaling from this receptor. This
may occur by blocking the recruitment of the SHP-2sion and on the circumstantial evidence from experi-
ments with neutralizing antibodies and SLAT overex- phosphatase to SLAM (Sayos et al., 1998) or, alterna-
tively, by recruiting FynT that then assembles a signalingpression. Such a claim would have been strengthened
if the effects of SLAT overexpression on nonpolarized complex including dok, SHIP, and RasGAP (Chan et al.,
2003; Latour et al., 2001, 2003). Signaling through SLAMT cell cultures had been measured.
What may be the role of SLAT in TCR signaling for in the absence of SAP favors Th1 differentiation, as
dramatically illustrated by the strong Th1 bias and theTh2 lineage differentiation? One should keep in mind
that the signaling events leading to T cell commitment defective generation of Th2 responses in SAP-deficient
mice (Wu et al., 2001). In contrast, the SLAM-SAP combi-and differentiation may involve multiple pathways, and
this increases the complexity of analysis at this early nation downregulates IFN- production and is required
for IL-4 production and the generation of a Th2 environ-stage of knowledge. However, we can start with the
simple assumption that SLAT contributes to the TCR ment. One can argue that SLAT may play a role similar
to that of SAP. Although the recruitment of SLAT to thesignaling pattern in Th2-committed cells and thus pro-
vides a proliferative/survival advantage for these cells. immunological synapse may be driven just by its PH
domain upon generation of PIP3, we cannot rule outSLAT may fulfill this role by acting as an adaptor to
assemble a TCR-dependent signalosome that is in- that a still uncharacterized receptor, which may be the
counterpart of SLAM, participates in this process. If true,volved in sustaining the early Th2 signaling pattern de-
scribed above. The domain structure of SLAT provides then one can argue that there is a common modular
basis for the delivery of signals that commit, promote,hints on how such an adaptor role may progress. Follow-
ing upregulation of SLAT expression in a TCR signaling- and maintain Th1/Th2 lineages, despite the availability
of signaling pathways from different receptors at eachdependent manner, SLAT is recruited to the immunologi-
cal synapse, maybe through interaction between its PH stage of differentiation. This commonality may help to
integrate the signals from the TCR, costimulatory mole-domain and phosphatidylinositol (3,4,5)triphosphate
(PIP3) (Costello et al., 2002). Following its recruitment to cules, and cytokine receptors (Zhu et al., 2000).
The idea that differential recruitment of adapters as-the synapse, SLAT would bind ZAP-70, either through
the imperfect ITAM motif or through an intermediate sembles selective signalosomes and leads to Th1 or
Th2 differentiation upon initial TCR-mediated signalingmolecule, and thus participate in the formation of a sig-
nalosome that favors Th2 differentiation. The associa- is highly reminiscent of the differential recruitment
model proposed to explain the unique signaling patterntion of SLAT with ZAP-70 decreases the function of this
kinase. From the data currently available, it is unclear if triggered by TCR partial agonists (Chau and Madrenas,
1999). According to this model, agonist ligands lead toSLAT sequesters ZAP-70 or, alternatively, inhibits the
activation of ZAP-70. In any case, downstream effects the formation of signalosomes on tyrosine phosphory-
lated LAT. These signalosomes include activating mole-of ZAP-70 activation, mostly dependent on LAT phos-
phorylation, do not occur. This model provides a molec- cules for the ras-MAPK pathways, the PLC-1 pathway,
and others. In contrast, the TCR partial agonist-inducedular basis for the observation that Th2 differentiation
often correlates with low levels of activation of ZAP-70 signalosome is assembled on incompletely phosphory-
lated TCR  chains, and includes only signaling mole-and with lack of phosphorylation of LAT (Boutin et al.,
1997). cules leading to activation of ERK-1/-2. This may explain
the selective activation of the ras-ERK pathway underAn additional function of SLAT, based on its homology
with SWAP-70, may be to act as a guanine-nucleotide ZAP-70-independent and phospho-LAT-independent
conditions of activation (Chau et al., 1998; Shan et al.,exchange factor (GEF). It has been recently reported
that SWAP-70 functions as a PIP3-dependent, ras-inde- 2001). As an extension of the differential recruitment
model, we propose that the Th1 and Th2 signalosomespendent rac-GEF (Shinohara et al., 2002). Although SLAT
does not have a highly conserved Dbl homology domain, would be formed on different adapters (LAT versus
SLAT?). This hypothesis is suggested by the differencesthe ERM domain may have such function as shown for
SWAP-70. If this holds true, one can argue that SLAT in lipid raft microdomain compartmentalization of TCR
components between Th1 and Th2 cells (Balamuth et al.,has a role as a GEF that regulates the activity of Rac1
or other Rho family GTPases, similar to the reported 2001). The similarities in the kinetics of TCR engagement
under Th2-favoring conditions and upon engagementassociation between Rac-2 and Th1 differentiation (Li
et al., 2000). Such a regulatory effect could favor differ- with TCR partial agonists translate into similar signaling
events and thus may likely have a similar molecularentiation along the Th2 pathway, for example by inte-
grating the CD28 costimulatory signals with those re- basis. It remains to be established how these partial
signaling patterns may offer a selective advantage forsulting from TCR engagement (Kaga et al., 1998).
Is there a common mechanism to deliver the signals Th2 differentiation.
The future should bring important new informationcausing preferential differentiation into the Th1 or the
Th2 lineages? The answer to this question may lie in the that will allow us to better understand the function of
SLAT. For example, it will be useful to identify otheremerging information about the interactions between
SLAM and SAP during T helper cell commitment and SLAT-associated proteins, to explore whether the low
levels of SLAT remaining in Th1 cells have any biologicaldifferentiation. SLAM is an activation-induced trans-
membrane molecule, expressed at high levels in Th1 implications, and to assess the contribution of costimu-
latory signals to the function of SLAT. It will also be verycells and at low levels in Th2 cells (Castro et al., 1999;
Cocks et al., 1995). Under basal conditions, a small interesting to elucidate the phenotype of SLAT-deficient
mice, especially as it relates to immune responsiveness.adaptor molecule, SAP, is constitutively bound to SLAM
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such as Tc1 and Tc2 or regulatory T cell subsets.
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